Clinical Trials Sponsored by Aju Pharm

Total 6857 results

AJU Pharm Co., Ltd.
OM Pharma SA

Recruiting

The Efficacy and Safety of OM-89 in Patients With Recurrent Chronic Prostatitis/Chronic Pelvic Pain Syndrome

Chronic Prostatitis With Chronic Pelvic Pain Syndrome | Chronic Prostatitis | Chronic Pelvic Pain Syndrome

Korea, Republic of
AJU Pharm Co., Ltd.

Recruiting

A Clinical Trial to Evaluate the Safety and Pharmacokinetics of AJU-C52L in Healthy Volunteers

Hypertension

Korea, Republic of
AJU Pharm Co., Ltd.

Completed

Efficacy and Safety of AJU-A51 in Type 2 Diabetes Mellitus Patients

Type2 Diabetes

Korea, Republic of
AJU Pharm Co., Ltd.

Completed

Evaluation of Pharmacokinetics and Safety of AJU-A51 in Healthy Adults

Diabetes Mellitus, Type 2

Korea, Republic of
AJU Pharm Co., Ltd.

Recruiting

A Clinical Trial to Evaluate the Safety and Pharmacokinetics of AJU-C52H in Healthy Volunteers

Hypertension

Korea, Republic of
AJU Pharm Co., Ltd.

Recruiting

Efficacy and Safety of AJU-C52 in Essential Hypertension Patients

Essential Hypertension

Korea, Republic of
AJU Pharm Co., Ltd.

Completed

The Drug-drug Interaction Study of AJU-A51R1 and AJU-A51R2

T2DM (Type 2 Diabetes Mellitus)

Korea, Republic of
AJU Pharm Co., Ltd.
GL Pharm Tech Corporation

Recruiting

Efficacy and Safety of AJU-S56 5% in Dry Eye Syndrome Patients

Dry Eye Syndromes

Korea, Republic of
AJU Pharm Co., Ltd.
GL Pharm Tech Corporation

Completed

Efficacy and Safety of AJU-S56 in Dry Eye Syndrome Patients

Dry Eye Syndromes

Korea, Republic of
Gachon University Gil Medical Center
Aju Pharm

Completed

Avastin/FOLFIRI in Combination With Curcumin in Colorectal Cancer Patients With Unresectable Metastasis

Colorectal Cancer
R-Pharm
Covance; Cromos Pharma LLC

Withdrawn

Study of the Efficacy and Safety of a Single Administration of Olokizumab vs. Placebo in Addition to Standard Treatment in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19).

COVID-19
UCB BIOSCIENCES, Inc.
R-Pharm

Terminated

Open-label Study to Assess the Safety and Efficacy of CDP6038 (Olokizumab) in Patients Who Completed RA0056

Rheumatoid Arthritis

United States, Belgium, United Kingdom
UCB BIOSCIENCES, Inc.
R-Pharm

Terminated

The Long-term Safety and Efficacy of CDP6038 (Olokizumab) With Active Rheumatoid Arthritis

Rheumatoid Arthritis

Japan, Korea, Republic of, Taiwan
AJI Pharma USA

Unknown

Phase II/III Study of the Tolerance and Efficacy of Combined Use of Didanosine (2',3'-Dideoxyinosine; ddI) and Lentinan in HIV-Positive Patients

HIV Infections

United States
AJI Pharma USA

Completed

Phase I/II Study of the Tolerance and Efficacy of Combined Use of Didanosine (2',3'-Dideoxyinosine; ddI) and Lentinan in HIV-Positive Patients

HIV Infections

United States
AJI Pharma USA

Completed

Phase I/II Study of Curdlan Sulfate

HIV Infections

United States
UCB Biopharma S.P.R.L.
Pharm Research Associates (UK) Ltd.

Completed

Study to Look at How Effective Briviact is as add-on Treatment for Patients With Epilepsy With Partial Onset Seizures (BASE)

Epilepsy With POS With or Without Secondary Generalization

Denmark, Germany, Hungary, Ireland, Italy, Netherlands, Norway, Spain, United Kingdom
R-Pharm Overseas, Inc.
R-Pharm; Data Management 365; Cromos Pharma LLC; Keystat, LLC; K-Research

Completed

Study to Evaluate the Effect on Parameters of Systemic Inflammation and Disease Outcomes and Safety of RPH-104 in Subjects With Acute ST-elevation Myocardial Infarction

Acute ST Segment Elevation Myocardial Infarction

United States, Russian Federation
ACU Medical Technologies Ltd

Completed

Testing the Efficiency of a Device Meant to Relieve Labour Pain

Labour Pain

Israel
Cleveland Clinic Abu Dhabi

Recruiting

Correlation Between New O3 Regional Oximetry, Electroencephalography and the Somatosensory Evoked Potential in Carotid Endarterectomy Surgery

Carotid Endarterectomy

United Arab Emirates
Cleveland Clinic Abu Dhabi

Not yet recruiting

P0.1 and Extubation Failure in Critically Ill Patients

Critically Ill | Weaning Failure | Mechanical Ventilation

France
Prove pharm

Recruiting

Indigotindisulfonate Sodium Injection, USP as an Aid in the Determination of Ureteral Patency

Ureter Injury

United States
R-Pharm

Completed

Study of Efficacy and Safety of TL-FVP-t vs. SOC in Patients With Mild to Moderate COVID-19

COVID-19

Russian Federation
Prove pharm

Completed

3,3'-Dioxo-2,2'-Bisindolylidene-5,5'-Disulfonate Disodium 0.8% Solution as an Aid for Ureteral Patency (UP)

Ureter Injury

United States
R-Pharm

Completed

Effect of Rifampin on the Pharmacokinetics of Ixabepilone in Patients With Advanced Cancer

Neoplasms | Advanced Solid Tumors

United States
R-Pharm

Completed

Clinical Study of Ixabepilone Administered as a 24 Hour Infusion in Patients With Solid Malignancies.

Solid Malignancies

United States
R-Pharm

Completed

Novel Epothilone Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer

Breast Cancer | Metastases

Belgium, Spain, United States, Argentina, Brazil, Canada, Germany, Peru, Taiwan, United Kingdom, Italy, France, Korea, Republic of, Philippines, Thailand, Mexico, Sweden, China, Hungary, Poland, Greece, Malaysia
Yuria-Pharm

Unknown

Efficacy and Safety of Rheosorbilact® Solution for Infusion, in a Complex Therapy of Burns

Burns | Intoxication

Kazakhstan, Moldova, Republic of, Ukraine, Uzbekistan
Hyundai Pharm

Completed

Phase III Study to Evaluate the Efficacy and Safety of HOB-048 CR Tab. in Comparison With HOB-048 Syrup in Patients With Cough Due to Acute or Chronic Bronchitis

Evaluate the Efficacy and Safety of Levotuss CR Tab. in Comparison With Levotuss Syrup in Patients With Cough Due to Acute or Chronic Bronchitis

Korea, Republic of
R-Pharm

Terminated

A Study of Ixabepilone as Second-line Therapy for Locally Advanced, Recurrent, or Metastatic Endometrial Cancer (IXAMPLE2)

Endometrial Cancer

Brazil, Czech Republic, Italy, Mexico, Russian Federation, Sweden, United Kingdom, United States, Spain, Canada, Denmark, France, Peru, Belgium, Hungary, Norway, Argentina, Australia, Greece
R-Pharm

Completed

Effect of Capecitabine on the Pharmacokinetics of BMS-247550 and BMS-247550 on the Pharmacokinetics of Capecitabine and Its Metabolites in Patients With Advanced Malignancies

Neoplasms | Advanced Solid Tumors

United States
R-Pharm

Completed

A Phase I Study of Ixabepilone in Combination With Capecitabine in Japanese Patients With Metastatic Breast Cancer

Breast Cancer

Japan
R-Pharm

Completed

A Phase II Combination of Trastuzumab and Ixabepilone Versus Trastuzumab and Docetaxel in Patients With Advanced and/or Metastatic Breast Cancer

Metastatic Breast Cancer

Italy, Turkey, Spain, France, Greece
R-Pharm

Completed

A Phase II, Trial of Ixabepilone Plus Cetuximab as First Line Therapy for Metastatic Pancreatic Cancer

Metastatic Pancreatic Cancer

United States
R-Pharm

Completed

Phase I Combination w/ Epirubicin

Metastatic Breast Cancer

Italy, France
GP-Pharm

Terminated

Efficacy and Safety Study of a New Leuprolide Acetate 17 mg Depot to Treat Prostate Cancer Patients

Prostate Cancer

United States
Prove pharm

Recruiting

Indigotindisulfonate Sodium Injection, USP as an Aid in the Determination of Ureteral Patency in Patient's With Renal Impairment

Ureter Injury

United States
Hyundai Pharm

Recruiting

Efficacy and Safety of HD-6277 in Adult Patients With Inadequate Control of Type 2 Diabetes Mellitus by Diet and Exercise

Type 2 Diabetes Mellitus

Korea, Republic of
Hyundai Pharm

Completed

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LINO-1713 in Healthy Korean Female Subjects

Contraception

Korea, Republic of
R-Pharm

Completed

Epothilone (Ixabepilone) Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer

Cancer | Breast Cancer

Turkey, Chile, Belgium, Portugal, Spain, Italy, United States, Argentina, Austria, Brazil, Canada, France, Germany, Singapore, South Africa, Taiwan, United Kingdom, Israel, Australia, Korea, Republic of, Russian Federation, Ireland, Netherland... and more
R-Pharm

Completed

Phase I Combination Ixabepilone + Cisplatin

Non Small Cell Lung Cancer

United States, Italy
R-Pharm

Completed

Study of Ixabepilone in Asian Subjects With Unresectable or Metastatic Gastric Cancer

Stomach Neoplasms

Korea, Republic of, Taiwan, Japan, Singapore, Hong Kong
Yuria-Pharm

Completed

Efficacy and Safety of Rheosorbilact® Solution for Infusion, in a Complex Therapy of Sepsis.

Sepsis | Intoxication; Septic

Georgia, Moldova, Republic of, Ukraine, Uzbekistan, Kazakhstan
Yuria-Pharm

Completed

Efficacy and Safety of Rheosorbilact® Solution for Infusion, in a Complex Therapy of Pneumonia

Pneumonia

Georgia, Moldova, Republic of, Kazakhstan, Ukraine, Uzbekistan, Vietnam
R-Pharm

Completed

Clinical Study of Ixabepilone (BMS-247550) by Every-3-week Dosing Regimen in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and Who Are Taxane Resistant

Metastatic Breast Cancer
R-Pharm

Completed

A Trial of 2 Schedules of Ixabepilone Plus Bevacizumab and Paclitaxel Plus Bevacizumab for Breast Cancer

Metastatic Breast Cancer

Italy, United Kingdom, United States, France, Spain
R-Pharm

Completed

Ixabepilone in Combination With Carboplatin in Patients With Non-small Cell Lung Cancer

Non-small Cell Lung Cancer (NSCLC)

Japan
R-Pharm

Completed

A Phase I Study of Oral Ixabepilone in Subjects With Advanced Cancer

Cancer

United States
R-Pharm

Completed

Randomized Phase II Study of Ixabepilone Alone and Ixabepilone Plus Cetuximab as First-Line Treatment for Female Subjects With Triple Negative Locally Advanced Non-resectable and/or Metastatic Breast Cancer

Metastatic Breast Cancer | Triple Negative Locally Advanced Non-resectable Breast Cancer

Czech Republic, Italy, Poland, Spain, Austria, France, Greece
R-Pharm

Completed

A Phase II Study of Epothilone Analog BMS-247550 in Patients With Non-Small Cell Lung Cancer Who Have Failed First Line Platinum Based Chemotherapy

Carcinoma, Non-small-cell Lung

United States

3

Subscribe